Navigating the Blind Spot: Rutgers Study Links Popular GLP-1 Medications to Rare, Serious Vision Risks
Executive Overview In the era of modern medicine, few pharmaceutical breakthroughs have captured public imagination and transformed global healthcare quite like the class of medications known as glucagon-like peptide-1 receptor…